{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:59:14Z","timestamp":1785131954320,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s12185-026-04196-0","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T19:11:54Z","timestamp":1776280314000},"page":"249-261","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of lymphocyte p-glycoprotein activity on development of graft-versus-host disease after stem cell transplantation"],"prefix":"10.1007","volume":"124","author":[{"given":"Shoji","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichiro","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Hirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Akashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0507-7309","authenticated-orcid":false,"given":"Mayako","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"4196_CR1","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/s41409-018-0204-7","volume":"53","author":"HM Schoemans","year":"2018","unstructured":"Schoemans HM, Lee SJ, Ferrara JL, Wolff D, Levine JE, Schultz KR, et al. EBMT-NIH-CIBMTR task force position statement on standardized terminology and guidance for graft-versus-host disease assessment. Bone Marrow Transplant. 2018;53:1401\u201315.","journal-title":"Bone Marrow Transplant"},{"key":"4196_CR2","doi-asserted-by":"publisher","first-page":"1320692","DOI":"10.3389\/fmed.2023.1320692","volume":"10","author":"A Di Francesco","year":"2023","unstructured":"Di Francesco A, Raiola AM, Dominietto A, Di Grazia C, Gualandi F, Van Lint MT, et al. Acute graft versus host disease 1976\u20132020: reduced incidence and predictive factors. Front Med (Lausanne). 2023;10:1320692.","journal-title":"Front Med (Lausanne)"},{"key":"4196_CR3","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1182\/blood-2011-06-364265","volume":"119","author":"M Jagasia","year":"2012","unstructured":"Jagasia M, Arora M, Flowers MED, Chao NJ, McCarthy PL, Cutler CS, et al. Risk factors for acute GVHD and survival after hematopoietic cell transplantation. Blood. 2012;119:296\u2013307.","journal-title":"Blood"},{"key":"4196_CR4","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1182\/bloodadvances.2023009885","volume":"7","author":"Y Akahoshi","year":"2023","unstructured":"Akahoshi Y, Spyrou N, Hogan WJ, Ayuk F, DeFilipp Z, Weber D, et al. Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD. Blood Adv. 2023;7:4479\u201391.","journal-title":"Blood Adv"},{"key":"4196_CR5","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1146\/annurev-immunol-102119-073227","volume":"39","author":"GR Hill","year":"2021","unstructured":"Hill GR, Betts BC, Tkachev V, Kean LS, Blazar BR. Current concepts and advances in graft-versus-host disease immunology. Annu Rev Immunol. 2021;39:19\u201349.","journal-title":"Annu Rev Immunol"},{"key":"4196_CR6","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1749-6632.1993.tb17137.x","volume":"696","author":"G Wiederrecht","year":"1993","unstructured":"Wiederrecht G, Lam E, Hung S, Martin M, Sigal N. The mechanism of action of FK-506 and cyclosporin A. Ann N Y Acad Sci. 1993;696:9\u201319.","journal-title":"Ann N Y Acad Sci"},{"key":"4196_CR7","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.bbmt.2018.12.766","volume":"25","author":"IS Hamadeh","year":"2019","unstructured":"Hamadeh IS, Zhang Q, Steuerwald N, Hamilton A, Druhan LJ, McSwain M, et al. Effect of CYP3A4, CYP3A5, and ABCB1 polymorphisms on intravenous tacrolimus exposure and adverse events in adult allogeneic stem cell transplant patients. Biol Blood Marrow Transplant. 2019;25:656\u201363.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4196_CR8","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1038\/s41598-025-87801-2","volume":"15","author":"N Yoshikawa","year":"2025","unstructured":"Yoshikawa N, Ehara Y, Yamada Y, Matsusaki Y, Shimoda K, Ikeda R. Time in therapeutic range of tacrolimus in allogeneic hematopoietic stem cell transplant recipients is associated with acute graft-versus-host disease prophylaxis. Sci Rep. 2025;15:3364.","journal-title":"Sci Rep"},{"key":"4196_CR9","doi-asserted-by":"publisher","first-page":"963689725136636","DOI":"10.1177\/09636897251366368","volume":"34","author":"A Nikoloudis","year":"2025","unstructured":"Nikoloudis A, Buxhofer-Ausch V, Kunte A, Groiss C, Mair L, Aichinger C, et al. The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: a retrospective analysis. Cell Transplant. 2025;34:9636897251366368.","journal-title":"Cell Transplant"},{"key":"4196_CR10","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.3390\/ijms20102413","volume":"20","author":"K Suetsugu","year":"2019","unstructured":"Suetsugu K, Mori Y, Yamamoto N, Shigematsu T, Miyamoto T, Egashira N, et al. Impact of CYP3A5, POR, and CYP2C19 polymorphisms on trough concentration to dose ratio of tacrolimus in allogeneic hematopoietic stem cell transplantation. Int J Mol Sci. 2019;20:2413.","journal-title":"Int J Mol Sci"},{"key":"4196_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030858","volume":"21","author":"J Zhu","year":"2020","unstructured":"Zhu J, Patel T, Miller JA, Torrice CD, Aggarwal M, Sketch MR, et al. Influence of germline genetics on tacrolimus pharmacokinetics and pharmacodynamics in allogeneic hematopoietic stem cell transplant patients. Int J Mol Sci. 2020;21:858.","journal-title":"Int J Mol Sci"},{"key":"4196_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/FTD.0000000000000640","volume":"41","author":"M Brunet","year":"2019","unstructured":"Brunet M, van Gelder T, \u00c5sberg A, Haufroid V, Hesselink DA, Langman L, et al. Therapeutic drug monitoring of tacrolimus-personalized therapy: second consensus report. Ther Drug Monit. 2019;41:261\u2013307.","journal-title":"Ther Drug Monit"},{"key":"4196_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1499388","volume":"7","author":"M Bossennec","year":"2018","unstructured":"Bossennec M, Di Roio A, Caux C, M\u00e9n\u00e9trier-Caux C. MDR1 in immunity: friend or foe? Oncoimmunology. 2018;7:e1499388.","journal-title":"Oncoimmunology"},{"key":"4196_CR14","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1182\/blood.V80.11.2735.bloodjournal80112735","volume":"80","author":"PM Chaudhary","year":"1992","unstructured":"Chaudhary PM, Mechetner EB, Roninson IB. Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood. 1992;80:2735\u20139.","journal-title":"Blood"},{"key":"4196_CR15","doi-asserted-by":"publisher","first-page":"6077","DOI":"10.1016\/S0021-9258(18)53221-X","volume":"268","author":"T Saeki","year":"1993","unstructured":"Saeki T, Ueda K, Tanigawara Y, Hori R, Komano T. Human P-glycoprotein transports cyclosporin A and FK506. J Biol Chem. 1993;268:6077\u201380.","journal-title":"J Biol Chem"},{"key":"4196_CR16","doi-asserted-by":"publisher","first-page":"13558","DOI":"10.1038\/srep13558","volume":"5","author":"J Liu","year":"2015","unstructured":"Liu J, Zhou F, Chen Q, Kang A, Lu M, Liu W, et al. Chronic inflammation up-regulates P-gp in peripheral mononuclear blood cells via the STAT3\/Nf-\u03bab pathway in 2,4,6-trinitrobenzene sulfonic acid-induced colitis mice. Sci Rep. 2015;5:13558.","journal-title":"Sci Rep"},{"key":"4196_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1432-2277.2011.01365.x","volume":"25","author":"A Capron","year":"2012","unstructured":"Capron A, Lerut J, Latinne D, Rahier J, Haufroid V, Wallemacq P. Correlation of tacrolimus levels in peripheral blood mononuclear cells with histological staging of rejection after liver transplantation: preliminary results of a prospective study: PBMCs tacrolimus levels and graft rejection. Transpl Int. 2012;25:41\u20137.","journal-title":"Transpl Int"},{"key":"4196_CR18","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.clinbiochem.2013.02.011","volume":"46","author":"F Lemaitre","year":"2013","unstructured":"Lemaitre F, Antignac M, Fernandez C. Monitoring of tacrolimus concentrations in peripheral blood mononuclear cells: application to cardiac transplant recipients. Clin Biochem. 2013;46:1538\u201341.","journal-title":"Clin Biochem"},{"key":"4196_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/j.1476-5381.2008.00050.x","volume":"156","author":"NJ Liptrott","year":"2009","unstructured":"Liptrott NJ, Penny M, Bray PG, Sathish J, Khoo SH, Back DJ, et al. The impact of cytokines on the expression of drug transporters, cytochrome P450 enzymes and chemokine receptors in human PBMC. Br J Pharmacol. 2009;156:497\u2013508.","journal-title":"Br J Pharmacol"},{"key":"4196_CR20","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01993-22","volume":"13","author":"SE Foley","year":"2022","unstructured":"Foley SE, Dente MJ, Lei X, Sallis BF, Loew EB, Meza-Segura M, et al. Microbial metabolites orchestrate a distinct multi-tiered regulatory network in the intestinal epithelium that directs P-glycoprotein expression. MBio. 2022;13:e0199322.","journal-title":"MBio"},{"key":"4196_CR21","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/sj.bmt.1703258","volume":"28","author":"CK Min","year":"2001","unstructured":"Min CK, Lee WY, Min DJ, Lee DG, Kim YJ, Park YH, et al. The kinetics of circulating cytokines including IL-6, TNF-alpha, IL-8 and IL-10 following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;28:935\u201340.","journal-title":"Bone Marrow Transplant"},{"key":"4196_CR22","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1016\/j.cell.2023.05.007","volume":"186","author":"CL Nguyen","year":"2023","unstructured":"Nguyen CL, Markey KA, Miltiadous O, Dai A, Waters N, Sadeghi K, et al. High-resolution analyses of associations between medications, microbiome, and mortality in cancer patients. Cell. 2023;186:2705-2718.e17.","journal-title":"Cell"},{"key":"4196_CR23","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/cyto.a.10039","volume":"53","author":"SW Park","year":"2003","unstructured":"Park SW, Lomri N, Simeoni LA, Fruehauf JP, Mechetner E. Analysis of P-glycoprotein-mediated membrane transport in human peripheral blood lymphocytes using the UIC2 shift assay. Cytometry A. 2003;53:67\u201378.","journal-title":"Cytometry A"},{"key":"4196_CR24","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bbmt.2015.09.001","volume":"22","author":"AC Harris","year":"2016","unstructured":"Harris AC, Young R, Devine S, Hogan WJ, Ayuk F, Bunworasate U, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai acute GVHD international consortium. Biol Blood Marrow Transplant. 2016;22:4\u201310.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4196_CR25","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s00262-020-02586-9","volume":"69","author":"Y Yan","year":"2020","unstructured":"Yan Y, Zheng L, Du Q, Yan B, Geller DA. Interferon regulatory factor 1 (IRF-1) and IRF-2 regulate PD-L1 expression in hepatocellular carcinoma (HCC) cells. Cancer Immunol Immunother. 2020;69:1891\u2013903.","journal-title":"Cancer Immunol Immunother"},{"key":"4196_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00384-007-0396-6","volume":"23","author":"S Yeruva","year":"2008","unstructured":"Yeruva S, Ramadori G, Raddatz D. NF-kappaB-dependent synergistic regulation of CXCL10 gene expression by IL-1beta and IFN-gamma in human intestinal epithelial cell lines. Int J Colorectal Dis. 2008;23:305\u201317.","journal-title":"Int J Colorectal Dis"},{"key":"4196_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.127","volume":"5","author":"L He","year":"2014","unstructured":"He L, Wang H-Y, Zhang L, Huang L, Li J-D, Xiong Y, et al. Prognostic significance of low DICER expression regulated by miR-130a in cervical cancer. Cell Death Dis. 2014;5:e1205.","journal-title":"Cell Death Dis"},{"key":"4196_CR28","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.31557\/APJCP.2019.20.4.1171","volume":"20","author":"M Talebi","year":"2019","unstructured":"Talebi M, Bahar Aghdam S, Azimi A, Mohammadi H, Karimi Yonjali S, Asariha M, et al. Regulatory effect of resveratrol and prednisolone on MDR1 protein expression in acute lymphoblastic leukemia cell line (CCRF-CEM). Asian Pac J Cancer Prev. 2019;20:1171\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4196_CR29","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1182\/blood.2022016926","volume":"140","author":"N Vallet","year":"2022","unstructured":"Vallet N, Le Grand S, Bondeelle L, Hoareau B, Corneau A, Bouteiller D, et al. Azithromycin promotes relapse by disrupting immune and metabolic networks after allogeneic stem cell transplantation. Blood. 2022;140:2500\u201313.","journal-title":"Blood"},{"key":"4196_CR30","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/cyto.a.21135","volume":"79","author":"V Vilas-Boas","year":"2011","unstructured":"Vilas-Boas V, Silva R, Gaio AR, Martins AM, Lima SC, Cordeiro-da-Silva A, et al. P-glycoprotein activity in human Caucasian male lymphocytes does not follow its increased expression during aging. Cytometry A. 2011;79:912\u20139.","journal-title":"Cytometry A"},{"key":"4196_CR31","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0022-1759(02)00020-0","volume":"262","author":"ER Meaden","year":"2002","unstructured":"Meaden ER, Hoggard PG, Khoo SH, Back DJ. Determination of P-gp and MRP1 expression and function in peripheral blood mononuclear cells in vivo. J Immunol Methods. 2002;262:159\u201365.","journal-title":"J Immunol Methods"},{"key":"4196_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.transproceed.2004.12.018","volume":"37","author":"EM Vasquez","year":"2005","unstructured":"Vasquez EM, Petrenko Y, Jacobssen V, Sifontis NM, Testa G, Sankary H, et al. An assessment of P-glycoprotein expression and activity in peripheral blood lymphocytes of transplant candidates. Transplant Proc. 2005;37:175\u20137.","journal-title":"Transplant Proc"},{"key":"4196_CR33","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.4049\/jimmunol.166.4.2451","volume":"166","author":"MH Frank","year":"2001","unstructured":"Frank MH, Denton MD, Alexander SI, Khoury SJ, Sayegh MH, Briscoe DM. Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro. J Immunol. 2001;166:2451\u20139.","journal-title":"J Immunol"},{"key":"4196_CR34","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.transproceed.2015.12.096","volume":"48","author":"S Limsrichamrern","year":"2016","unstructured":"Limsrichamrern S, Chanapul C, Mahawithitwong P, Sirivatanauksorn Y, Kositamongkol P, Asavakarn S, et al. Correlation of hematocrit and tacrolimus level in liver transplant recipients. Transplant Proc. 2016;48:1176\u20138.","journal-title":"Transplant Proc"},{"key":"4196_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11095-020-02875-z","volume":"37","author":"N Yoshikawa","year":"2020","unstructured":"Yoshikawa N, Yokota T, Matsuo A, Matsumoto N, Iwakiri T, Ikeda R. Role of FK506 binding protein on tacrolimus distribution in red blood cells. Pharm Res. 2020;37:143.","journal-title":"Pharm Res"},{"key":"4196_CR36","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/TP.0000000000004287","volume":"107","author":"S Udomkarnjananun","year":"2023","unstructured":"Udomkarnjananun S, Francke MI, Dieterich M, van De Velde D, Litjens NHR, Boer K, et al. P-glycoprotein, FK-binding protein-12, and the intracellular tacrolimus concentration in T-lymphocytes and monocytes of kidney transplant recipients. Transplantation. 2023;107:382\u201391.","journal-title":"Transplantation"},{"key":"4196_CR37","doi-asserted-by":"publisher","first-page":"e0153491","DOI":"10.1371\/journal.pone.0153491","volume":"11","author":"SS Han","year":"2016","unstructured":"Han SS, Yang SH, Kim MC, Cho J-Y, Min S-I, Lee JP, et al. Monitoring the intracellular tacrolimus concentration in kidney transplant recipients with stable graft function. PLoS ONE. 2016;11:e0153491.","journal-title":"PLoS ONE"},{"key":"4196_CR38","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1182\/blood-2011-02-334821","volume":"118","author":"T Luft","year":"2011","unstructured":"Luft T, Dietrich S, Falk C, Conzelmann M, Hess M, Benner A, et al. Steroid-refractory GVHD: T cell attack within a vulnerable endothelial system. Blood. 2011;118:1685\u201392.","journal-title":"Blood"},{"key":"4196_CR39","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1182\/blood.2021011867","volume":"138","author":"R Chakraverty","year":"2021","unstructured":"Chakraverty R, Teshima T. Graft-versus-host disease: a disorder of tissue regeneration and repair. Blood. 2021;138:1657\u201365.","journal-title":"Blood"},{"key":"4196_CR40","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1038\/s41467-021-23071-6","volume":"12","author":"EL Giddings","year":"2021","unstructured":"Giddings EL, Champagne DP, Wu M-H, Laffin JM, Thornton TM, Valenca-Pereira F, et al. Mitochondrial ATP fuels ABC transporter-mediated drug efflux in cancer chemoresistance. Nat Commun. 2021;12:2804.","journal-title":"Nat Commun"},{"key":"4196_CR41","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1124\/dmd.119.089953","volume":"48","author":"D You","year":"2020","unstructured":"You D, Richardson JR, Aleksunes LM. Epigenetic regulation of multidrug resistance protein 1 and breast cancer resistance protein transporters by histone deacetylase inhibition. Drug Metab Dispos. 2020;48:459\u201380.","journal-title":"Drug Metab Dispos"},{"key":"4196_CR42","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/s41419-018-0625-7","volume":"9","author":"M Dyczynski","year":"2018","unstructured":"Dyczynski M, Vesterlund M, Bj\u00f6rklund A-C, Zachariadis V, Janssen J, Gallart-Ayala H, et al. Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment. Cell Death Dis. 2018;9:846.","journal-title":"Cell Death Dis"},{"key":"4196_CR43","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drup.2017.10.003","volume":"32","author":"I Genovese","year":"2017","unstructured":"Genovese I, Ilari A, Assaraf YG, Fazi F, Colotti G. Not only P-glycoprotein: amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins. Drug Resist Updat. 2017;32:23\u201346.","journal-title":"Drug Resist Updat"},{"key":"4196_CR44","first-page":"429","volume":"88","author":"R Basiric\u00f2","year":"2003","unstructured":"Basiric\u00f2 R, Pirrotta R, Fabbiano F, Mirto S, Cascio L, Pagano M, et al. Submicroscopic deletions at 7q region are associated with recurrent chromosome abnormalities in acute leukemia. Haematologica. 2003;88:429\u201337.","journal-title":"Haematologica"},{"key":"4196_CR45","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12185-023-03591-1","volume":"118","author":"K Noguchi","year":"2023","unstructured":"Noguchi K, Ikawa Y, Takenaka M, Sakai Y, Fujiki T, Kuroda R, et al. L-asparaginase as an efficient salvage therapy for refractory acute myeloid leukemia with chromosome 7 abnormalities: a case series. Int J Hematol. 2023;118:406\u201310.","journal-title":"Int J Hematol"},{"key":"4196_CR46","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/FTD.0000000000000780","volume":"42","author":"F Lemaitre","year":"2020","unstructured":"Lemaitre F, Vethe NT, D\u2019Avolio A, Tron C, Robertsen I, De Winter B, et al. Measuring intracellular concentrations of calcineurin inhibitors: expert consensus from the international association of therapeutic drug monitoring and clinical toxicology expert panel. Ther Drug Monit. 2020;42:665\u201370.","journal-title":"Ther Drug Monit"},{"key":"4196_CR47","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","volume":"15","author":"M Tomblyn","year":"2009","unstructured":"Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143\u2013238.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4196_CR48","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/cpdd.1043","volume":"11","author":"J Scheuenpflug","year":"2022","unstructured":"Scheuenpflug J, Kropeit D, Erb-Zohar K, Theis JGW, Stobernack H-P, McCormick D, et al. The effect of oral letermovir administration on the pharmacokinetics of a single oral dose of P-glycoprotein substrate digoxin in healthy volunteers. Clin Pharmacol Drug Dev. 2022;11:6\u201315.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"4196_CR49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/cpdd.280","volume":"6","author":"T Yamazaki","year":"2017","unstructured":"Yamazaki T, Desai A, Goldwater R, Han D, Lasseter KC, Howieson C, et al. Pharmacokinetic interactions between isavuconazole and the drug transporter substrates atorvastatin, digoxin, metformin, and methotrexate in healthy subjects. Clin Pharmacol Drug Dev. 2017;6:66\u201375.","journal-title":"Clin Pharmacol Drug Dev"},{"key":"4196_CR50","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/jac\/dkae103","volume":"79","author":"R Lewis","year":"2024","unstructured":"Lewis R, Niazi-Ali S, McIvor A, Kanj SS, Maertens J, Bassetti M, et al. Triazole antifungal drug interactions-practical considerations for excellent prescribing. J Antimicrob Chemother. 2024;79:1203\u201317.","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04196-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-026-04196-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-026-04196-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T05:04:41Z","timestamp":1785128681000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-026-04196-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["4196"],"URL":"https:\/\/doi.org\/10.1007\/s12185-026-04196-0","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"22 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The wrong Supplementary file was originally published with this article with red text; it has now been replaced with the correct file.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}